In conclusion, we presented a dominant epitope of SARS-CoV-2 S from the PBMCs of COVID-19 convalescent patients, represented by the peptide B65, together with its specific functional TCR for CD4+ T cells. The gene discussed is CD4; the disease is COVID-19.